Table 3 Clinicopathological characteristics based on pathological tumor stage and histopathological subtype
Histopathological subtype | Value | pN0 | pN(+) | p value |
|---|---|---|---|---|
Adenocarcinoma (n = 145) | (n = 116) | (n = 29) | ||
SUVmaxe | 2.1 [1.08–3.38] | 4.3 [3.0–7.2] | < 0.001 | |
SUVmaxd | 2.6 [1.2–4.7] | 5.9 [4.1–8.9] | < 0.001 | |
RI | 0.16 [0.0–0.30] | 0.29 [0.17–0.40] | < 0.01 | |
pT | 19 [14–25] | 25 [21–30] | < 0.01 | |
Squamous cell carcinoma (n = 53) | (n = 44) | (n = 9) | ||
SUVmaxe | 5.9 [3.77–8.55] | 9.3 [6.60–14.20] | 0.02 | |
SUVmaxd | 8.1 [4.58–11.95] | 13.4 [9.4–18.5] | 0.03 | |
RI | 0.33 [0.25–0.45] | 0.33 [0.28–0.44] | 0.62 | |
pT | 27 [19.8–32.0] | 33 [32–42] | 0.05 | |
Other (n = 20) | (n = 14) | (n = 6) | ||
SUVmaxe | 5.3 [2.28–8.28] | 7.0 [6.65–7.43] | 0.39 | |
SUVmaxd | 6.5 [2.88–11.10] | 9.1 [8.53–9.75] | 0.39 | |
RI | 0.23 [0.17–0.38] | 0.29 [0.26–0.30] | 0.34 | |
pT | 21.5 [12.3–27.0] | 27.0 [24.8–44.3] | 0.23 |